Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Continuous Renal Replacement Therapy Market, by Region, 2020-2030 (USD Billion)
1.2.2. Continuous Renal Replacement Therapy Market, by Product, 2020-2030 (USD Billion)
1.2.3. Continuous Renal Replacement Therapy Market, by Modality, 2020-2030 (USD Billion)
1.2.4. Continuous Renal Replacement Therapy Market, by Age Group, 2020-2030 (USD Billion)
1.2.5. Continuous Renal Replacement Therapy Market, by End User, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Continuous Renal Replacement Therapy Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Continuous Renal Replacement Therapy Market Dynamics
3.1. Continuous Renal Replacement Therapy Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of Acute Kidney Injury (AKI)
3.1.1.2. Growing clinical advantage of CRRT over intermittent blood purification
3.1.2. Market Challenges
3.1.2.1. Lack of standard treatment guidelines in developing nations
3.1.2.2. High complexity of CRRT
3.1.3. Market Opportunities
3.1.3.1. Development of CRRT from simple renal replacement treatment to multi-organ support therapy
3.1.3.2. Rising emphasis on the research activities to establish safety and efficacy profile of CRRT
Chapter 4. Global Continuous Renal Replacement Therapy Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Continuous Renal Replacement Therapy Market, by Product
5.1. Market Snapshot
5.2. Global Continuous Renal Replacement Therapy Market by Product, Performance - Potential Analysis
5.3. Global Continuous Renal Replacement Therapy Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
5.4. Continuous Renal Replacement Therapy Market, Sub Segment Analysis
5.4.1. Dialysates and Replacement Fluids
5.4.2. Disposables
5.4.3. Hemofilters
5.4.4. Bloodline Sets & Tubes
5.4.5. Other Disposables
5.4.6. CRRT Systems
Chapter 6. Global Continuous Renal Replacement Therapy Market, by Modality
6.1. Market Snapshot
6.2. Global Continuous Renal Replacement Therapy Market by Modality, Performance - Potential Analysis
6.3. Global Continuous Renal Replacement Therapy Market Estimates & Forecasts by Modality 2020-2030 (USD Billion)
6.4. Continuous Renal Replacement Therapy Market, Sub Segment Analysis
6.4.1. Continuous venovenous hemofiltration (CVVH)
6.4.2. Continuous venovenous hemodiafiltration (CVVHDF)
6.4.3. Continuous venovenous haemodialysis (CVVHD)
6.4.4. Slow continuous ultrafiltration (SCUF)
Chapter 7. Global Continuous Renal Replacement Therapy Market, by Age Group
7.1. Market Snapshot
7.2. Global Continuous Renal Replacement Therapy Market by Age Group, Performance - Potential Analysis
7.3. Global Continuous Renal Replacement Therapy Market Estimates & Forecasts by Age Group 2020-2030 (USD Billion)
7.4. Continuous Renal Replacement Therapy Market, Sub Segment Analysis
7.4.1. Adults
7.4.2. Pediatrics /Neonates
Chapter 8. Continuous Renal Replacement Therapy Market, by End User
8.1. Market Snapshot
8.2. Global Continuous Renal Replacement Therapy Market by End User, Performance - Potential Analysis
8.3. Global Continuous Renal Replacement Therapy Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
8.4. Continuous Renal Replacement Therapy Market, Sub Segment Analysis
8.4.1. Hospital
8.4.2. Ambulatory care
8.4.3. Homecare
8.4.4. Others
Chapter 9. Global Continuous Renal Replacement Therapy Market, Regional Analysis
9.1. Top Leading Countries
9.2. Top Emerging Countries
9.3. Continuous Renal Replacement Therapy Market, Regional Market Snapshot
9.4. North America Continuous Renal Replacement Therapy Market
9.4.1. U.S. Continuous Renal Replacement Therapy Market
9.4.1.1. Product breakdown estimates & forecasts, 2020-2030
9.4.1.2. Modality breakdown estimates & forecasts, 2020-2030
9.4.1.3. Age Group breakdown estimates & forecasts, 2020-2030
9.4.1.4. End User breakdown estimates & forecasts, 2020-2030
9.4.2. Canada Continuous Renal Replacement Therapy Market
9.5. Europe Continuous Renal Replacement Therapy Market Snapshot
9.5.1. U.K. Continuous Renal Replacement Therapy Market
9.5.2. Germany Continuous Renal Replacement Therapy Market
9.5.3. France Continuous Renal Replacement Therapy Market
9.5.4. Spain Continuous Renal Replacement Therapy Market
9.5.5. Italy Continuous Renal Replacement Therapy Market
9.5.6. Rest of Europe Continuous Renal Replacement Therapy Market
9.6. Asia-Pacific Continuous Renal Replacement Therapy Market Snapshot
9.6.1. China Continuous Renal Replacement Therapy Market
9.6.2. India Continuous Renal Replacement Therapy Market
9.6.3. Japan Continuous Renal Replacement Therapy Market
9.6.4. Australia Continuous Renal Replacement Therapy Market
9.6.5. South Korea Continuous Renal Replacement Therapy Market
9.6.6. Rest of Asia Pacific Continuous Renal Replacement Therapy Market
9.7. Latin America Continuous Renal Replacement Therapy Market Snapshot
9.7.1. Brazil Continuous Renal Replacement Therapy Market
9.7.2. Mexico Continuous Renal Replacement Therapy Market
9.8. Middle East & Africa Continuous Renal Replacement Therapy Market
9.8.1. Saudi Arabia Continuous Renal Replacement Therapy Market
9.8.2. South Africa Continuous Renal Replacement Therapy Market
9.8.3. Rest of Middle East & Africa Continuous Renal Replacement Therapy Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Company 1
10.1.2. Company 2
10.1.3. Company 3
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Baxter
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Recent Developments
10.3.2. B Braun SE
10.3.3. Fresenius Medical Care AG & Co. KGaA
10.3.4. Asahi Kasei Medical Co., Ltd. (Asahi Kasei Corporation)
10.3.5. NIPRO Corporation
10.3.6. Toray Medical Co, Ltd. (Toray Industries, Inc.)
10.3.7. Nikkiso Co., Ltd.
10.3.8. Medtronic PLC
10.3.9. Medica SpA
10.3.10. Medical Components, Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption